Petros Pharmaceuticals annual free cash flow
2020
2024
Petros Pharmaceuticals Free Cash Flow (FCF) History (PTPI)
Petros Pharmaceuticals reported −$2.6M in free cash flow for fiscal 2024, an increase of $12.7M from the previous fiscal year, with a free cash flow margin of −51.40%.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$2.6M | $12.7M | — | −51.40% |
| 2020 | 2020-12-31 | −$15.3M | — | — | −160.15% |
Petros Pharmaceuticals quarterly free cash flow
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2020 | 2020-12-31 | −$4.5M | — | — | −154.40% |
| Q3 2020 | 2020-09-30 | −$2.7M | — | — | −76.99% |
| Q2 2020 | 2020-06-30 | −$5.7M | — | — | −417.89% |
| Q1 2020 | 2020-03-31 | −$2.4M | — | — | −132.80% |
Petros Pharmaceuticals free cash flow growth trends
Petros Pharmaceuticals's latest reported quarter, Q4 2020, generated −$4.5M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Petros Pharmaceuticals filings at SEC.gov ↗